Imperial and DNDi strengthen partnership to accelerate treatments for neglected diseases

Researchers from Imperial College London and the Drugs for Neglected Diseases initiative (DNDi) met on 19 January to strengthen a growing partnership focused on developing new treatments, diagnostics and digital tools for diseases that disproportionately affect people in low- and middle-income countries (LMICs).